Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
11 mg QD to 15 mg QD PF-066497511件: Tavapadon (PF-06649751)1件: Tavapadon 💬 2件: DRD1,
DRD5 💬 		10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6 💬
21 mg QD to 7 mg QD PF-06649751 (if de-escalated in parent study)1件: Tavapadon (PF-06649751)1件: Tavapadon 💬 2件: DRD1,
DRD5 💬 		10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6 💬
315 mg QD de-escalated to 7 mg QD PF-06649751 in parent study remain at 7 mg QD1件: Tavapadon (PF-06649751)1件: Tavapadon 💬 2件: DRD1,
DRD5 💬 		10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6 💬
415 mg QD PF-066497511件: Tavapadon (PF-06649751)1件: Tavapadon 💬 2件: DRD1,
DRD5 💬 		10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6 💬
53 mg QD to 15 mg QD PF-066497511件: Tavapadon (PF-06649751)1件: Tavapadon 💬 2件: DRD1,
DRD5 💬 		10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6 💬
63 mg QD to 7 mg QD PF-06649751 (de-escalated in parent study)1件: Tavapadon (PF-06649751)1件: Tavapadon 💬 2件: DRD1,
DRD5 💬 		10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6 💬
77 mg QD to 15 mg QD PF-066497511件: Tavapadon (PF-06649751)1件: Tavapadon 💬 2件: DRD1,
DRD5 💬 		10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6 💬
87 mg QD to 7 mg QD PF-06649751 (de-escalated in parent study)1件: Tavapadon (PF-06649751)1件: Tavapadon 💬 2件: DRD1,
DRD5 💬 		10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6 💬
9PF-066497511件: Tavapadon (PF-06649751)1件: Tavapadon 💬 2件: DRD1,
DRD5 💬 		10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6 💬
10PF-06649751 - 15mg1件: Tavapadon (PF-06649751)1件: Tavapadon 💬 2件: DRD1,
DRD5 💬 		10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6 💬
11PF-06649751 - 1mg1件: Tavapadon (PF-06649751)1件: Tavapadon 💬 2件: DRD1,
DRD5 💬 		10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6 💬
12PF-06649751 - 5mg1件: Tavapadon (PF-06649751)1件: Tavapadon 💬 2件: DRD1,
DRD5 💬 		10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6 💬
13PF-06649751 high dose (15 mg QD)1件: Tavapadon (PF-06649751)1件: Tavapadon 💬 2件: DRD1,
DRD5 💬 		10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6 💬
14PF-06649751 low dose (1 mg QD)1件: Tavapadon (PF-06649751)1件: Tavapadon 💬 2件: DRD1,
DRD5 💬 		10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6 💬
15PF-06649751 middle dose 1 (3 mg QD)1件: Tavapadon (PF-06649751)1件: Tavapadon 💬 2件: DRD1,
DRD5 💬 		10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6 💬
16PF-06649751 middle dose 2 (7 mg QD)1件: Tavapadon (PF-06649751)1件: Tavapadon 💬 2件: DRD1,
DRD5 💬 		10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6 💬